1. P.10.2 GUT-VASCULAR BARRIER IN PATIENTS WITH HYPERTRANSAMINASEMIA ASSOCIATED WITH UNTREATED COELIAC DISEASE. Issue 2 (15th March 2018) Authors: Naviglio, S.; De Leo, L.; Vatta, S.; Benelli, E.; Giuffrida, P.; Stera, G.; Santon, D.; Ziberna, F.; Martelossi, S.; Di Sabatino, A.; Ventura, A.; Not, T. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease. (8th October 2015) Authors: Naviglio, S.; Stocco, G.; Cuzzoni, E.; Favretto, D.; De Iudicibus, S.; Lucafò, M.; Fabris, M.; Cifù, A.; Martelossi, S.; Taddio, A.; Ventura, A.; Decorti, G. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 4 Page Start: e264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reversible Henoch–Schönlein purpura complicating adalimumab therapy in a young patient with ulcerative colitis. (10th October 2016) Authors: Bramuzzo, M.; Naviglio, S.; Martelossi, S. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 4 Page Start: e264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗